| Field | Specification |
|---|---|
| Target | |
| Alternative names | Cadherin-2; CDw325; Neural cadherin; N-cadherin; CD antigen CD325; CDH2; CDHN; NCAD |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthetic peptide corresponding to a sequence at the C-terminus of human Cadherin/CDH2, which shares 95% and 100% amino acid (aa) sequence identity with mouse and rat Cadherin/CDH2, respectively. |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody recognizes cadherin-2 (gene CDH2) in human samples and is validated for Western blot.
N-cadherin (CDH2) is a classical cadherin that mediates calcium-dependent adhesion in neural tissue, heart muscle, and other mesenchymal cells. It helps organize neural development and cardiac intercalated discs, and its gain during epithelial–mesenchymal transition makes it a common marker in cancer invasion studies.
| Target | Cadherin-2 (gene CDH2; UniProt P19022, human) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Human |
| Purification | Immunogen affinity purified |
| Form | Lyophilized |
| Formulation | Per vial: 4 mg trehalose; 0.9 mg NaCl; 0.2 mg Na2HPO4; 0.01 mg NaN3 |
| Reconstitution | 500 µg/mL after adding 0.2 mL distilled water |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 0.25–0.5 µg/mL (Human) |
|---|
Immunogen
Synthetic peptide from the C-terminal region of human cadherin/CDH2. Sequence identity with the mouse and rat orthologs: 95% and 100%, respectively.
Reactivity Notes
The supplier lists reactivity with human. UniProt places cadherin-2 in the cell membrane, cell junction, cell surface and cell projection.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Shuning Han et al. (2024) MiR-1290 induces endothelial-to-mesenchymal transition and promotes vascular restenosis after angioplasty by targeting FGF2. Atherosclerosis. 10.1016/j.atherosclerosis.2024.118527
Liang Zhang et al. (2019) SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a. Artificial Cells Nanomedicine and Biotechnology. 10.1080/21691401.2019.1575840
Jiatao Wu et al. (2024) Expression and potential molecular mechanism of TOP2A in metastasis of non-small cell lung cancer. Scientific Reports. 10.1038/s41598-024-63055-2
Yuguang Yang et al. (2020) RETRACTED ARTICLE: STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A. Cell Cycle. 10.1080/15384101.2020.1757936
Zhu Lifei et al. (2020) RETRACTED ARTICLE: Long non-coding RNA MIAT promotes the growth of melanoma via targeting miR-150. Human Cell. 10.1007/s13577-020-00340-y
Wenjuan Li et al. (2024) PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT. BMC Cancer. 10.1186/s12885-024-12390-8
Miao-Yun Long et al. (2020) Comprehensive circular RNA profiling reveals the regulatory role of circRNA_0007694 in papillary thyroid carcinoma. American Journal of Translational Research. PMID: 32355548
Jingjing Qiao et al. (2019) Knockdown of ROS proto-oncogene 1 inhibits migration and invasion in gastric cancer cells by targeting the PI3K/Akt signaling pathway. OncoTargets and Therapy. 10.2147/OTT.S213421
Xu Weiran et al. (2018) Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/β-catenin signaling in gastric cancer cells. Bioscience Biotechnology and Biochemistry. 10.1080/09168451.2018.1431518
ShengJie Dai et al. (2024) Expression of the laminin genes family and its relationship to prognosis in pancreatic carcinoma. Arab Journal of Gastroenterology. 10.1016/j.ajg.2024.07.006
